COLL
Collegium Pharmaceutical, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables):
amplitud de titulares -8.3% ·
flujo de acciones +2.9% ·
nuevas posiciones netas -9.1%
— fórmula
Acumulación concentrada — aumento de acciones entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +3 | 27.25M | $986.22M | +8 | −5 |
| Q1 2026 | 98 | -1 | 28.14M | $930.88M | +7 | −9 |
| Q4 2025 | 100 | 0 | 26.92M | $1.25B | +1 | — |
| Q3 2025 | 19 | +2 | 14.79M | $517.39M | +2 | — |
| Q2 2025 | 14 | +1 | 12.36M | $365.37M | +1 | — |
| Q1 2025 | 10 | -1 | 5.48M | $163.49M | — | −1 |
| Q4 2024 | 11 | -1 | 5.00M | $143.28M | — | −1 |
| Q3 2024 | 11 | -1 | 3.77M | $145.78M | — | −1 |
| Q2 2024 | 12 | — | 3.67M | $118.10M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 1.66M | +8.1% | $63.99M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 775.58K | +0.7% | $29.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 775.58K | +0.7% | $29.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Arrowstreet Capital ✦ | 276.73K | +280.4% | $10.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 265.60K | +33.6% | $10.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 265.60K | +33.6% | $10.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 206.41K | -19.0% | $7.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 133.95K | -55.9% | $5.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 131.34K | -23.9% | $5.08M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 131.34K | -23.9% | $5.08M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 129.01K | +26.5% | $4.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 129.01K | +26.5% | $4.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 114.64K | +17.1% | $4.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 114.64K | +17.1% | $4.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 114.64K | +17.1% | $4.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 114.64K | +17.1% | $4.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 52.11K | -15.2% | $2.01M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 31.16K | +1.0% | $1.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Marshall Wace | $2.29M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 5.10M acciones, $5.91M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.